Thank you for supporting journalism at your local newspaper. This article is available exclusively for our subscribers, who help fund our work at Navarre Press.
Washington (AP) — Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That’s raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease.
The remainder of this article is available only for our website subscribers, who help fund our mission of keeping you updated on news you want and need to know. You can become a subscriber for as little as $5.67 a month.
